PFE

PFE

USD

Pfizer Inc. Common Stock

$24.610-0.725 (-2.862%)

Real-time Price

Healthcare
Drug Manufacturers - General
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$25.335

High

$25.430

Low

$24.530

Volume

34.84M

Company Fundamentals

Market Cap

139.9B

Industry

Drug Manufacturers - General

Country

United States

Trading Stats

Avg Volume

42.78M

Exchange

NYQ

Currency

USD

52-Week Range

Low $20.92Current $24.610High $31.54

Related News

Analyst Upgrades

Pfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

View more
Pfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook
Analyst Upgrades

Pfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

View more
Pfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook
BusinessWire

ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression

Multiple real-world studies show consistent high effectiveness of Vocabria + Rekambys (cabotegravir + rilpivirine LA (CAB+RPV LA)) across a broad range of populations Implementation science data for Apretude

View more
ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression
Reuters

GSK seeks FDA nod for expanded use of RSV vaccine in adults

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults under the age of 50 at a higher risk of the disease.

View more
GSK seeks FDA nod for expanded use of RSV vaccine in adults
Reuters

EU's von der Leyen survives parliament confidence vote

European Commission President Ursula von der Leyen survived a no-confidence vote in European Parliament on Thursday, tabled by mainly far-right lawmakers who said she and her team undermined trust in the EU through unlawful actions.

View more
EU's von der Leyen survives parliament confidence vote
CNBC

Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others

Trump's "big beautiful" bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of digital health funding this year.

Reuters

Activist investor Starboard Value discloses 9% stake in Tripadvisor

Activist investor Starboard Value disclosed a 9% stake in online travel firm Tripadvisor , according to a filing submitted to the U.S. Securities and Exchange Commission on Thursday.